784 related articles for article (PubMed ID: 29484373)
1. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
[TBL] [Abstract][Full Text] [Related]
2. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue.
Chen M; Shen M; Li Y; Liu C; Zhou K; Hu W; Xu B; Xia Y; Tang W
Int J Mol Med; 2015 Dec; 36(6):1607-14. PubMed ID: 26459747
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
4. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.
Xu Y; Zheng X; Qiu Y; Jia W; Wang J; Yin S
J Proteome Res; 2015 Aug; 14(8):3315-21. PubMed ID: 26130307
[TBL] [Abstract][Full Text] [Related]
5. A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma.
Shen CT; Zhang Y; Liu YM; Yin S; Zhang XY; Wei WJ; Sun ZK; Song HJ; Qiu ZL; Wang CR; Luo QY
Clin Endocrinol (Oxf); 2017 Dec; 87(6):844-852. PubMed ID: 28755525
[TBL] [Abstract][Full Text] [Related]
6. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach.
Lu J; Hu S; Miccoli P; Zeng Q; Liu S; Ran L; Hu C
Oncotarget; 2016 Dec; 7(49):81768-81777. PubMed ID: 27835583
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary findings for metabolite profiles of papillary thyroid carcinoma and laryngeal squamous cell carcinoma].
Fei MJ; Xu YN; Wang JD
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 31(20):1561-1565. PubMed ID: 29797950
[No Abstract] [Full Text] [Related]
9. NMR-based metabolomics to select a surgical method for treating papillary thyroid carcinoma.
Wang B; Zhang LY; Wang SS; Yang YH; Zhao WX
Clinics (Sao Paulo); 2018 Nov; 73():e333. PubMed ID: 30462753
[TBL] [Abstract][Full Text] [Related]
10. Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma.
Seo JW; Han K; Lee J; Kim EK; Moon HJ; Yoon JH; Park VY; Baek HM; Kwak JY
PLoS One; 2018; 13(3):e0193883. PubMed ID: 29509799
[TBL] [Abstract][Full Text] [Related]
11. Metabolite signature of human malignant thyroid tissue: A systematic review and meta-analysis.
Razavi SA; Khorsand B; Salehipour P; Hedayati M
Cancer Med; 2024 Apr; 13(8):e7184. PubMed ID: 38646957
[TBL] [Abstract][Full Text] [Related]
12. Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma.
Wang Z; Yang Y; Xing Y; Si D; Wang S; Lin J; Li C; Zhang J; Yin D
Sci Rep; 2023 Oct; 13(1):17666. PubMed ID: 37848492
[TBL] [Abstract][Full Text] [Related]
13. [The characteristic of metabolics of female papillary thyroid carcinoma and its relationship with primary tumor size and cervical lymph node metastases].
Zheng WJ; Xu YN; Zhou QY; Chen J; Fei MJ; Wang JD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 51(2):105-11. PubMed ID: 26898866
[TBL] [Abstract][Full Text] [Related]
14. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Profiles and Blood Biomarkers to Discriminate between Benign Thyroid Nodules and Papillary Carcinoma, Based on UHPLC-QTOF-ESI
Berinde GM; Socaciu AI; Socaciu MA; Petre GE; Socaciu C; Piciu D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542465
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic Alterations in Thyrospheres and Adherent Parental Cells in Papillary Thyroid Carcinoma Cell Lines: A Pilot Study.
Caria P; Tronci L; Dettori T; Murgia F; Santoru ML; Griffin JL; Vanni R; Atzori L
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262749
[TBL] [Abstract][Full Text] [Related]
17. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.
Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M
Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of papillary thyroid carcinoma by
Wang T; Sun Z; Wang Y; Li F; Zhou X; Tian X; Wang S
Drug Discov Ther; 2020 Sep; 14(4):187-196. PubMed ID: 32848112
[TBL] [Abstract][Full Text] [Related]
19. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
